CLGN · CollPlant Biotechnologies Ltd
Market Cap
$7.34M
Shares
1.89M
Volume · Oct 20
20.36K
Avg daily vol (32 sessions)
80.78K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.88
Open$3.57
Day$3.53–3.88
52W close$2.73–24.90
Avg vol 30d72K
Short int42K · 2.2% float · 1.0d
Short vol79%
Last earningsSep 30, 2024
DataJan 2020–Oct 2026
Up next
Date not confirmed
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$318,000
Trailing 12 months
Net income (TTM)
−$12.51M
Trailing 12 months
Revenue growth YoY
-28.1%
Year over year
Operating margin
-3,900.9%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-153.8%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+3.4%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
2.2%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−30%
below
Price vs 50-day avg
+9%
above
RSI (14)
53
neutral
MACD trend
Negative
52-week position
5%
near low
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+4%
trailing
YTD return
−72%
this year
Relative strength
−4%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $4 › 200d $6 — 200d above 50d
Institutional flow
Distributing
2 of 15 funds reported for Sep 30 · net -2.7K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.23% of float · ▼ -19.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 3-yr range
Squeeze score
55
elevated · 0–100
Fundamentals
Revenue growth
+360%
Y/Y
Gross margin
65%
expanding
EPS growth
+35%
Y/Y
Free cash flow
$-9.4M
Balance sheet
$13.1M
net cash
Quant / Vol
risk profile
Volatility
115%
annualized · 1-yr
Max drawdown
−89%
past year
ATR
11.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−30%
Bearish
Price vs 50-day avg
+9%
Bullish
RSI (14)
53
Neutral
MACD trend
Negative
Bearish
52-week position
5%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $4 › 200d $6 — 200d above 50d
Institutional flow
Distributing
2 of 15 funds reported for Sep 30 · net -2.7K sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.23% of float · ▼ -19.2% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
15 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $3
Now $4 · 5%
Range high $25
vs 200-day avg -30%
vs 50-day avg +9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CLGN
this stock
CollPlant Biotechnologies Ltd
|
$7.34M | — | +360.4% | — | 2.2% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$130.07B | +13.5% | +46.2% | 29.9 | 1.8% |
|
MRNA
Moderna, Inc.
|
$96.65B | +720.9% | +4.3% | — | 7.7% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$83.13B | +4.6% | +20.8% | 20.0 | 2.1% |
|
CSLLY
Csl Ltd
|
$66.34B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
14
- % held
- 8.7%
- Reported
- 2 of 15
- Top holder
- VILLERE ST DENIS J & CO L…
Held
Float
Short & Settlement
Financials
Filings
SEC Filings
Latest
6-K
- Filed
- Oct 15, 2026
- This year
- 30
CollPlant Biotechnologies Ltd. closed a private placement on October 14, 2026, raising approximately $3.7 million gross through 989,301 ordinary shares or pre-funded warrants and warrants for up to 1,483,950 ordinary shares at $3.74 per share.
ViewEarnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CLGN | -0.8% | +0.8% | +4.0% | +2.7% | -72.3% |
| SPY | -1.2% | -0.6% | +8.1% | +0.8% | +12.8% |
| vs SPY | +0.4% | +1.3% | -4.1% | +1.8% | -85.1% |